These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4042927)

  • 1. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
    Drago F; Motta A; Grossi E
    J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of therapy-refractory depressions].
    Pöldinger W; Alac S; Krebs-Roubicek E
    Act Nerv Super (Praha); 1982 May; 24(2):55-62. PubMed ID: 6125075
    [No Abstract]   [Full Text] [Related]  

  • 6. Maprotiline (Ludiomil) treatment of mental depression--a clinical report of 65 cases.
    Li SW; Yan HQ
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(3):139-41. PubMed ID: 2594736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new compound of tetracyclic structure, maprotiline (Ludiomil) in the treatment of depression.
    Zák F; Szebeni R
    Ther Hung; 1985; 33(2):83-9. PubMed ID: 3842006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
    Ridges AP
    Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
    [No Abstract]   [Full Text] [Related]  

  • 11. EEG characteristics of clinically defined on-drug-responders and non-responders--a comparison clomipramine vs. maprotiline.
    Ulrich G; Haug HJ; Stieglitz RD; Fähndrich E
    Pharmacopsychiatry; 1988 Nov; 21(6):367-8. PubMed ID: 3244769
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of antidepressants in childhood: results of maprotiline (Ludiomil) treatment in 20 cases.
    Minuti E; Gallo V
    Adv Biochem Psychopharmacol; 1982; 32():223-7. PubMed ID: 7090893
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of sleep deprivation as a predictor of treatment response to antidepressant medication.
    Fähndrich E
    Acta Psychiatr Scand; 1983 Nov; 68(5):341-4. PubMed ID: 6650211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of therapy-resistant depression with Ludiomil].
    Pethö B; Karczag I
    Orv Hetil; 1983 Oct; 124(44):2683-5. PubMed ID: 6359009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Depressive states, occurrence and treatment in family practice. Randomized study of the efficacy of maprotiline (Ludiomil) and flupenthixol (Fluanxol)].
    Sederberg-Olsen P; Lauritsen B; Husfeldt P; Rønne H; Ekstrøm K; Bjørndal F; Holst B; Jakobsen K
    Ugeskr Laeger; 1981 May; 143(22):1383-7. PubMed ID: 7027568
    [No Abstract]   [Full Text] [Related]  

  • 16. Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression.
    Ridges AP; Bishop FM; Lawton K; Goldberg IJ
    Postgrad Med J; 1980; 56 Suppl 1():37-41. PubMed ID: 6156444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative clinical study of the association of chlordiazepoxide-amitriptyline and maprotiline in patients suffering from depression with anxiety components].
    Tsaras G; Ambrus J
    Rev Med Suisse Romande; 1981 Jun; 101(6):483-6. PubMed ID: 7029696
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability.
    Clin Ther; 1983; 5(4):377-84. PubMed ID: 6347381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.